Left ventricular volume and wall stress are linked to lung function impairment in COPD.

[1]  J. Hohlfeld,et al.  Effect of lung deflation with indacaterol plus glycopyrronium on ventricular filling in patients with hyperinflation and COPD (CLAIM): a double-blind, randomised, crossover, placebo-controlled, single-centre trial. , 2018, The Lancet. Respiratory medicine.

[2]  J. Wedzicha,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. , 2017, American journal of respiratory and critical care medicine.

[3]  N. Eves,et al.  Heart-lung interaction in a model of COPD: importance of lung volume and direct ventricular interaction. , 2016, American journal of physiology. Heart and circulatory physiology.

[4]  N. Sverzellati,et al.  Left ventricular structure and remodeling in patients with COPD , 2016, International journal of chronic obstructive pulmonary disease.

[5]  R. Holle,et al.  The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline. , 2016, Respiratory medicine.

[6]  S. Petersen,et al.  Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial. , 2016, American journal of respiratory and critical care medicine.

[7]  A. Gemma,et al.  COPD advances in left ventricular diastolic dysfunction , 2016, International journal of chronic obstructive pulmonary disease.

[8]  A. Hofman,et al.  Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. , 2016, American journal of respiratory and critical care medicine.

[9]  C. Vogelmeier,et al.  Wall stress determines systolic and diastolic function--Characteristics of heart failure. , 2016, International journal of cardiology.

[10]  J. Yim,et al.  Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data , 2015, International journal of chronic obstructive pulmonary disease.

[11]  Y. Oh,et al.  Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease , 2015, International journal of chronic obstructive pulmonary disease.

[12]  T. Greulich,et al.  Airflow limitation in COPD is associated with increased left ventricular wall stress in coincident heart failure. , 2015, Respiratory medicine.

[13]  J. Soriano,et al.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.

[14]  R. Zuwallack,et al.  An official American Thoracic Society/European Respiratory Society statement: research questions in COPD , 2015, European Respiratory Review.

[15]  R. Goldberg,et al.  Impact of COPD on the mortality and treatment of patients hospitalized with acute decompensated heart failure: the Worcester Heart Failure Study. , 2015, Chest.

[16]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  M. Bottai,et al.  Survival in COPD: Impact of Lung Dysfunction and Comorbidities , 2014, Medicine.

[18]  Benjamin M. Smith,et al.  Impaired left ventricular filling in COPD and emphysema: is it the heart or the lungs? The Multi-Ethnic Study of Atherosclerosis COPD Study. , 2013, Chest.

[19]  A. Agustí,et al.  Cardiovascular comorbidity in COPD: systematic literature review. , 2013, Chest.

[20]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[21]  K. Klose,et al.  Increased end diastolic wall stress precedes left ventricular hypertrophy in dilative heart failure--use of the volume-based wall stress index. , 2012, International journal of cardiology.

[22]  B. Nordestgaard,et al.  Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. , 2011, European heart journal.

[23]  R Merget,et al.  Body plethysmography--its principles and clinical use. , 2011, Respiratory medicine.

[24]  H. Magnussen,et al.  Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. , 2010, Chest.

[25]  Eric A. Hoffman,et al.  Percent emphysema, airflow obstruction, and impaired left ventricular filling. , 2010, The New England journal of medicine.

[26]  A. Chaouat,et al.  Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease and Interstitial Lung Diseases , 2009, Seminars in respiratory and critical care medicine.

[27]  Mary B Wagner,et al.  Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress. , 2009, American journal of physiology. Heart and circulatory physiology.

[28]  S. Solomon,et al.  Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) , 2009, European journal of heart failure.

[29]  M. Decramer,et al.  A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.

[30]  P. Calverley,et al.  Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. , 2008, American journal of respiratory and critical care medicine.

[31]  K. Klose,et al.  B-type natriuretic peptide and wall stress in dilated human heart , 2008, Molecular and Cellular Biochemistry.

[32]  Konrad Schultz,et al.  Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD) , 2007 .

[33]  G. Viegi,et al.  Standardisation of the measurement of lung volumes , 2005, European Respiratory Journal.

[34]  Shinsuke Yuasa,et al.  Analysis of the electrophysiological properties and arrhythmias in directly contacted skeletal and cardiac muscle cell sheets. , 2005, Cardiovascular research.

[35]  J. Marcus,et al.  Early changes of cardiac structure and function in COPD patients with mild hypoxemia. , 2005, Chest.

[36]  E. Prescott,et al.  Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study , 2003, European Respiratory Journal.

[37]  V. Peinado,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease , 2003, European Respiratory Journal.

[38]  B. Hedblad,et al.  Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function: A Study From “Men Born in 1914,” Malmö, Sweden , 2001, Circulation.

[39]  P. Bentler,et al.  Cutoff criteria for fit indexes in covariance structure analysis : Conventional criteria versus new alternatives , 1999 .

[40]  B. Celli,et al.  Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. , 1996, American journal of respiratory and critical care medicine.

[41]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[42]  P. Schnohr,et al.  Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. , 1991, The European respiratory journal.

[43]  W Grossman,et al.  Cardiac hypertrophy: useful adaptation or pathologic process? , 1980, The American journal of medicine.

[44]  A. Buda,et al.  Effect of intrathoracic pressure on left ventricular performance. , 1979, The New England journal of medicine.